rosiglitazone has been researched along with Hepatocellular Carcinoma in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.57) | 18.2507 |
| 2000's | 13 (46.43) | 29.6817 |
| 2010's | 13 (46.43) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Chen, Y; Fu, L; Zhang, L | 1 |
| Chae, YR; Cho, IS; Jang, SY; Kim, GR; Kim, JH; Nam, CM; Yoo, HR | 1 |
| Dansako, H; Gu, W; Kato, N; Nishitsuji, H; Satoh, S; Shimotohno, K; Ueda, Y | 1 |
| Li, J; Liu, L; Liu, Y; Sun, J; Xia, S; Xu, D; Xu, Y; Yang, Z; Zhang, L; Zou, F | 1 |
| Herrigel, DJ; Moss, RA | 1 |
| Cao, LQ; Jiang, XF; Liang, HH; Shao, ZL; Xue, P; Yang, XW; Zhang, DW | 1 |
| Chang, YF; Chen, HC; Chi, CW; Hsia, CY; Hsu, HT; Lee, HC; Weng, JW | 1 |
| Cao, LQ; Chen, JS; Chen, XL; Fu, XH; Huang, XH; Jiao, XY; Lu, HW; Peng, HP; Wang, Q; Wang, XL; Xue, P; Zheng, Q | 1 |
| Liang, ZQ; Peng, L; Xu, Z; Yang, T; Zhang, M; Zhou, Y | 1 |
| Chan, HL; Cheng, AS; Cheung, KF; Chu, ES; Feng, H; Lam, CN; Shen, B; Sung, JJ; Teoh, N; To, KF; Wang, S; Wu, CW; Yu, J; Zhao, J | 1 |
| Cao, LQ; Peng, HP; Shao, ZL; Xia, T; Xiao, JB | 1 |
| Crabb, DW; Liangpunsakul, S; Lu, C; Sozio, MS; Zeng, Y | 1 |
| Cheng, JT; Chu, ES; Farrell, GC; Li, G; Lo, CM; Man, K; Nie, Y; Shen, B; Sung, JJ; Teoh, N; Wu, CW; Yu, J; Zhao, G | 1 |
| Davaa, E; Park, JS | 1 |
| Cheng, AS; Cheung, KF; Hao, Y; Li, X; Lowe, AW; Sung, JJ; Yu, J; Zhao, J | 1 |
| Bugelski, P; Elcock, F; Hahn, L; Hart, T; McFarland, D; Morgan, DG; Narayanan, PK; Schwartz, L; Zhang, C | 1 |
| Ehrenborg, E; Hall, K; Hilding, A; Lewitt, MS; Skogsberg, J | 1 |
| Katoh, M; Maniratanachote, R; Minami, K; Nakajima, M; Yokoi, T | 1 |
| Borkan, SC; Matsuhashi, N; Nakajima, A; Ohnishi, S; Saubermann, LJ; Schaefer, KL; Takahashi, H; Turner, JR; Wada, K; Wolfe, MM | 1 |
| Jin, J; Li, Z; Wang, L; Wu, N; Zha, XL; Zhang, W | 1 |
| Blann, E; Dial, S; Dragan, YP; Guo, L; Muskhelishvili, L; Schroth, G; Shi, L; Sun, Y; Zhang, L | 1 |
| Gao, L; Hong, B; Jiang, W; Si, S; Wang, M; Yang, Y; Zhang, Z; Zhao, G; Zheng, Z | 1 |
| Kersten, S; Lichtenauer-Kaligis, E; Mandard, S; Müller, M; Richardson, TA; Stienstra, R; Tan, NS; Trautwein, C; Wahli, W | 1 |
| Bi, J; Cao, LQ; Chen, XL; Huang, XH; Li, W; Wang, Q; Zhang, LJ; Zhen, MC | 1 |
| Baek, HA; Choi, HN; Chung, MJ; Jang, KY; Kim, KR; Lee, HJ; Moon, WS; Park, HS | 1 |
| Baugé, E; Chinetti, G; Clavey, V; Copin, C; Dallongeville, J; Fruchart, J; Fruchart, JC; Mariotte, MC; Staels, B | 1 |
| Beale, EG; Duplus, E; Forest, C; Glorian, M; Granner, DK; Scott, DK | 1 |
| Nakajima, M; Yamamoto, Y; Yamazaki, H; Yokoi, T | 1 |
2 review(s) available for rosiglitazone and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Inhibiting Sodium Taurocholate Cotransporting Polypeptide in HBV-Related Diseases: From Biological Function to Therapeutic Potential.
Topics: Carcinoma, Hepatocellular; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Hepatocytes; Humans; Interferons; Liver Neoplasms; Nucleotides; Organic Anion Transporters, Sodium-Dependent; Symporters; Virus Internalization | 2022 |
Diabetes mellitus as a novel risk factor for gastrointestinal malignancies.
Topics: Adenocarcinoma; Carcinoma, Hepatocellular; Colorectal Neoplasms; Diabetes Complications; Humans; Hypoglycemic Agents; Insulin; Liver Neoplasms; Metformin; Non-alcoholic Fatty Liver Disease; Pancreatic Neoplasms; Pioglitazone; Precancerous Conditions; Receptors, Somatomedin; Risk Factors; Rosiglitazone; Thiazolidinediones | 2014 |
26 other study(ies) available for rosiglitazone and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Statistical methods for elimination of guarantee-time bias in cohort studies: a simulation study.
Topics: Algorithms; Bias; Carcinoma, Hepatocellular; Cohort Studies; Computer Simulation; Humans; Hypoglycemic Agents; Liver Neoplasms; Models, Statistical; Proportional Hazards Models; Risk Factors; Rosiglitazone; Thiazolidinediones; Time Factors | 2017 |
A new hepatoma cell line exhibiting high susceptibility to hepatitis B virus infection.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cyclosporine; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Host-Pathogen Interactions; Humans; Liver Neoplasms; Organic Anion Transporters, Sodium-Dependent; Rosiglitazone; Symporters; Virus Internalization | 2019 |
Inhibition of oxidative stress-elicited AKT activation facilitates PPARγ agonist-mediated inhibition of stem cell character and tumor growth of liver cancer cells.
Topics: AC133 Antigen; Animals; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Glycoproteins; Humans; Liver Neoplasms; Male; Membrane Glycoproteins; Mice; Mice, Nude; NADPH Oxidase 2; NADPH Oxidases; Neoplastic Stem Cells; Oxidative Stress; Peptides; Phenotype; PPAR gamma; Prostaglandin D2; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Ribonucleosides; Rosiglitazone; Thiazolidinediones | 2013 |
Activation of peroxisome proliferator-activated receptor-γ (PPARγ) inhibits hepatoma cell growth via downregulation of SEPT2 expression.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Caspase 7; Caspase 9; Cell Movement; Cell Proliferation; Computational Biology; Down-Regulation; Electrophoresis, Gel, Two-Dimensional; Hep G2 Cells; Humans; Liver Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; PPAR gamma; Proteomics; RNA Interference; Rosiglitazone; Septins; Signal Transduction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Thiazolidinediones; Transfection | 2015 |
Combined effect of honokiol and rosiglitazone on cell growth inhibition through enhanced G0/G1 phase arrest in hepatoma cells.
Topics: Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; G1 Phase Cell Cycle Checkpoints; Humans; Lignans; Liver Neoplasms; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2016 |
Rosiglitazone sensitizes hepatocellular carcinoma cell lines to 5-fluorouracil antitumor activity through activation of the PPARgamma signaling pathway.
Topics: Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Cyclooxygenase 2; Down-Regulation; Drug Resistance, Neoplasm; Fluorouracil; Humans; Liver Neoplasms; PPAR alpha; PTEN Phosphohydrolase; Rosiglitazone; Thiazolidinediones; Transcriptional Activation; Tumor Cells, Cultured | 2009 |
[Effect of rosiglitazone on cells cycle, apoptosis and expression of Skp2 and p27Kip1 in hepatocellular carcinoma cell line].
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p27; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; PTEN Phosphohydrolase; Rosiglitazone; S-Phase Kinase-Associated Proteins; Thiazolidinediones | 2010 |
Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro.
Topics: Adenoviridae; Alkylating Agents; Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Diethylnitrosamine; Gene Expression Profiling; Growth Differentiation Factor 15; Humans; Hypoglycemic Agents; Liver Neoplasms, Experimental; Male; Mice; Mice, Knockout; Oligonucleotide Array Sequence Analysis; PPAR gamma; Rosiglitazone; Thiazolidinediones; Up-Regulation | 2010 |
Rosiglitazone enhances 5-fluorouracil-induced cell growth inhibition in hepatocellular carcinoma cell line Hep3B.
Topics: Animals; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Female; Fluorouracil; Gene Silencing; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; PPAR gamma; PTEN Phosphohydrolase; RNA, Small Interfering; Rosiglitazone; Signal Transduction; Thiazolidinediones; Tumor Burden | 2010 |
Activated AMPK inhibits PPAR-{alpha} and PPAR-{gamma} transcriptional activity in hepatoma cells.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Liver Neoplasms; Metformin; PPAR alpha; PPAR gamma; Rats; Ribonucleosides; Rosiglitazone; Thiazolidinediones; Transcriptional Activation | 2011 |
PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice.
Topics: Animals; Biomarkers, Tumor; Blotting, Western; Cadherins; Carcinoma, Hepatocellular; Cell Adhesion; Cell Movement; Chromatin Immunoprecipitation; Gene Expression Profiling; Humans; Hypoglycemic Agents; In Vitro Techniques; Liver Neoplasms; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Oligonucleotide Array Sequence Analysis; PPAR gamma; Real-Time Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Tumor Cells, Cultured | 2012 |
Formulation parameters influencing the physicochemical characteristics of rosiglitazone-loaded cationic lipid emulsion.
Topics: Biological Transport; Carcinoma, Hepatocellular; Castor Oil; Cations; Chemistry, Pharmaceutical; Drug Carriers; Drug Stability; Emulsions; Fatty Acids, Monounsaturated; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Hypoglycemic Agents; Insulin Resistance; Lipids; Liver Neoplasms; Nanoparticles; Particle Size; Phosphatidylethanolamines; Polysorbates; Quaternary Ammonium Compounds; Rosiglitazone; Solubility; Surface-Active Agents; Technology, Pharmaceutical; Thiazolidinediones | 2012 |
CITED2 is a novel direct effector of peroxisome proliferator-activated receptor γ in suppressing hepatocellular carcinoma cell growth.
Topics: Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinases; Down-Regulation; Gene Knockdown Techniques; Humans; Liver Neoplasms; PPAR gamma; Repressor Proteins; Rosiglitazone; Thiazolidinediones; Trans-Activators; Transfection | 2013 |
Troglitazone-induced intracellular oxidative stress in rat hepatoma cells: a flow cytometric assessment.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Cell Membrane; Chromans; Coloring Agents; Dose-Response Relationship, Drug; Fibrinolytic Agents; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Glutathione; Membrane Potentials; Mitochondria; Models, Chemical; Oxidative Stress; Oxygen; Phenanthridines; Propidium; Rats; Rosiglitazone; Superoxides; Thiazolidinediones; Troglitazone | 2003 |
Troglitazone stimulates IGF-binding protein-1 by a PPAR gamma-independent mechanism.
Topics: Carcinoma, Hepatocellular; Chromans; Gene Expression Regulation, Neoplastic; Humans; Hypoglycemic Agents; Insulin-Like Growth Factor Binding Protein 1; Kinetics; Liver Neoplasms; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Troglitazone; Tumor Cells, Cultured | 2003 |
Chaperone proteins involved in troglitazone-induced toxicity in human hepatoma cell lines.
Topics: Amino Acid Sequence; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Chromans; Dose-Response Relationship, Drug; Endoplasmic Reticulum Chaperone BiP; Gene Expression Regulation; Heat-Shock Proteins; Humans; Hypoglycemic Agents; Liver Neoplasms; Molecular Chaperones; Molecular Sequence Data; Protein Disulfide-Isomerases; Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones; Transfection; Troglitazone | 2005 |
Peroxisome proliferator-activated receptor gamma inhibition prevents adhesion to the extracellular matrix and induces anoikis in hepatocellular carcinoma cells.
Topics: Anilides; Anoikis; Benzamides; Carcinoma, Hepatocellular; Cell Adhesion; Cell Growth Processes; Cell Line, Tumor; Cell Shape; Chromans; Extracellular Matrix; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Integrin beta1; Liver Neoplasms; PPAR gamma; Protein-Tyrosine Kinases; Pyridines; Rosiglitazone; Thiazolidinediones; Troglitazone | 2005 |
PPARgamma activator rosiglitazone inhibits cell migration via upregulation of PTEN in human hepatocarcinoma cell line BEL-7404.
Topics: Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Focal Adhesion Kinase 1; Humans; Hypoglycemic Agents; Immunoblotting; Liver Neoplasms; Luciferases; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; PPAR gamma; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Signal Transduction; Thiazolidinediones; Tumor Cells, Cultured; Up-Regulation | 2006 |
Differences in hepatotoxicity and gene expression profiles by anti-diabetic PPAR gamma agonists on rat primary hepatocytes and human HepG2 cells.
Topics: Animals; Carcinoma, Hepatocellular; Cells, Cultured; Chromans; Cluster Analysis; Gene Expression Profiling; Gene Expression Regulation; Hepatocytes; Humans; Hypoglycemic Agents; Liver Neoplasms; Pioglitazone; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Transcription, Genetic; Troglitazone | 2006 |
Identification of novel human high-density lipoprotein receptor Up-regulators using a cell-based high-throughput screening assay.
Topics: Actinomycetaceae; Biological Assay; Carbocyanines; Carcinoma, Hepatocellular; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fermentation; Fluorescent Dyes; Gene Expression Regulation; Genes, Reporter; Humans; Hydroxyl Radical; Isoflavones; Lipoproteins, HDL; Liver Neoplasms; Luciferases; PPAR gamma; Receptors, Lipoprotein; Recombinant Fusion Proteins; Rosiglitazone; Scavenger Receptors, Class B; Thiazolidinediones; Transcription, Genetic; Up-Regulation | 2007 |
The Interleukin-1 receptor antagonist is a direct target gene of PPARalpha in liver.
Topics: Animals; Anticholesteremic Agents; Carcinoma, Hepatocellular; Female; Gene Expression Regulation; Hepatitis; Hepatocytes; Humans; Hypoglycemic Agents; Interleukin 1 Receptor Antagonist Protein; Liver; Male; Mice; Mice, Knockout; PPAR alpha; Promoter Regions, Genetic; Pyrimidines; Receptors, Interleukin-1 Type I; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Tumor Cells, Cultured; Up-Regulation | 2007 |
Upregulation of PTEN involved in rosiglitazone-induced apoptosis in human hepatocellular carcinoma cells.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Line; Humans; Hypoglycemic Agents; Liver Neoplasms; Phosphatidylinositol 3-Kinases; PPAR gamma; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Rosiglitazone; Signal Transduction; Thiazolidinediones; Up-Regulation | 2007 |
A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
Topics: Anilides; Benzamides; Blotting, Western; Carcinoma, Hepatocellular; Cell Adhesion; Cell Growth Processes; Cell Line, Tumor; Cell Movement; Chromans; Colony-Forming Units Assay; Humans; Hypoglycemic Agents; Immunoenzyme Techniques; Ligands; Liver Neoplasms; Neoplasm Invasiveness; PPAR gamma; Pyridines; Rosiglitazone; Thiazolidinediones; Troglitazone; Vimentin | 2007 |
Cell culture conditions determine apolipoprotein CIII secretion and regulation by fibrates in human hepatoma HepG2 cells.
Topics: Animals; Anticholesteremic Agents; Apolipoprotein C-III; Apolipoproteins; Apolipoproteins C; Blood; Carcinoma, Hepatocellular; Cattle; Culture Media; DNA-Binding Proteins; Fenofibrate; Gemfibrozil; Gene Expression Regulation, Neoplastic; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Kinetics; Liver Neoplasms; Pyrimidines; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Tumor Cells, Cultured | 1999 |
A single element in the phosphoenolpyruvate carboxykinase gene mediates thiazolidinedione action specifically in adipocytes.
Topics: 3T3 Cells; Adipocytes; Adipose Tissue; Animals; Carcinoma, Hepatocellular; Gene Expression; Hypoglycemic Agents; Male; Mice; Phosphoenolpyruvate Carboxykinase (GTP); Promoter Regions, Genetic; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Repetitive Sequences, Nucleic Acid; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 2001 |
Cytotoxicity and apoptosis produced by troglitazone in human hepatoma cells.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Survival; Chromans; DNA Fragmentation; Dose-Response Relationship, Drug; Humans; Hypoglycemic Agents; Pioglitazone; Rosiglitazone; Tetrazolium Salts; Thiazoles; Thiazolidinediones; Troglitazone; Tumor Cells, Cultured | 2001 |